Dr. Steven Gundry's Olive Oil: What to Know

Dr. Steven Gundry promotes olive oil as a lectin-free food. Here's what the science actually says about his claims, his brand (Prelude), and olive oil's role in his protocol.

The Gundry Protocol: A Brief Overview

Dr. Steven Gundry is a former heart surgeon who transitioned into nutritional医学 and wellness through his "Plant Paradox" program. For a complete overview, see our Best Olive Oil Brands guide.His central thesis — that lectins (a class of proteins found in many plant foods) cause chronic inflammation and contribute to a range of health problems — has attracted both a significant following and substantial scientific criticism.

The Gundry Protocol recommends avoiding most grains, legumes, nightshades, and certain seeds, while encouraging consumption of foods he considers lectin-light or lectin-free. Among the foods he recommends: olive oil, avocado oil, and coconut oil — he considers these "safe" fats that do not trigger the inflammatory response he attributes to lectins1.

Olive Oil's Place in the Gundry Diet

Within the Plant Paradox framework, olive oil is specifically endorsed as a beneficial fat source. Gundry writes that extra virgin olive oil does not contain meaningful lectin content and may have anti-inflammatory properties that offset some of the inflammatory effects he attributes to other dietary lectins1.

He also has his own brand, Prelude, which sells "Gundry MD Olive Oil" — marketed as a high-phenol, low-lectin olive oil with third-party testing to verify polyphenol content and absence of lectin proteins. A 30mL serving of Prelude is marketed as delivering at least 300mg/kg total polyphenols and testing below the detection threshold for lectins1.

What the Evidence Says About Gundry's Claims

The lectin hypothesis has limited support in mainstream nutritional science. Here's the current evidence landscape:

On lectins and inflammation: Lectins are proteins that bind to carbohydrates. Some lectins (like those in raw red kidney beans) are genuinely toxic if not properly prepared. However, the hypothesis that dietary lectins cause the widespread systemic inflammation Gundry describes is not well-supported by clinical evidence. Most lectins are significantly reduced or denatured by cooking, fermentation, or processing1.

On olive oil and inflammation: The evidence here is strong and consistent, independent of lectin theory. Extra virgin olive oil's polyphenols — particularly hydroxytyrosol and oleocanthal — have documented anti-inflammatory activity in cell culture, animal, and human studies1. The EFSA authorized a health claim for olive oil polyphenols' contribution to protection of blood lipids from oxidative stress1. This is not controversial science.

On the "lectin-free" framing of olive oil: Olive oil is a fruit juice, not a legume or grain. It is not a significant source of lectins by any measure. Gundry's endorsement of olive oil is correct — but it's correct for reasons that have nothing to do with the lectin hypothesis. The same evidence that supports olive oil's health benefits exists whether or not lectins are a valid concern.

On Prelude specifically: There is no peer-reviewed published research on Prelude's olive oil product. The company's claims about polyphenol content are based on their own third-party testing, which has not been independently verified in the scientific literature. The polyphenol levels they claim (300+ mg/kg) are achievable by many Quality EVOO producers at similar or lower prices.

Evaluating the Claims Carefully

Gundry's olive oil recommendations are consistent with mainstream nutritional science in the specific foods he endorses. He is right that olive oil is a safe, health-supportive fat for most people. The evidence base for olive oil's benefits is broad and robust11^.

Where Gundry goes beyond the evidence is in attributing the benefits to the avoidance of lectins rather than to the direct effects of olive oil's phenolic compounds and fatty acid composition. This framing is his trademark but not the explanation the science supports.

What olive oil actually does (regardless of lectin theory)

The documented health effects of regular EVOO consumption include:

  • Cardioprotective effects: the PREDIMED trial found 30% reduction in major cardiovascular events in Mediterranean populations consuming ~50mL/day of EVOO
  • Anti-inflammatory activity: polyphenols inhibit pro-inflammatory signaling pathways (COX-2, NF-κB) at physiologically relevant concentrations
  • Endothelial function improvement: olive oil polyphenols improve nitric oxide bioavailability and blood vessel dilation
  • Oxidative stress reduction: direct antioxidant effects of hydroxytyrosol and related compounds
  • Potential anti-cancer effects: cell culture and animal data, with ongoing human studies

These effects are documented in peer-reviewed literature and do not require the lectin framework to be valid.

The Verdict

Gundry is not wrong to recommend olive oil. On this specific point, the mainstream nutritional consensus supports him: olive oil is a health-positive food that most people would benefit from consuming more of.

Where his framework goes beyond the evidence is in attributing benefits specifically to lectin avoidance, and in selling a premium-priced branded product (Prelude) while making claims not independently verified in published research.

If you want to consume more olive oil for its documented health benefits — as part of a Mediterranean-style diet, a DASH-style approach, or any evidence-based dietary pattern — you don't need to follow the Gundry Protocol to do it. Standard dietary guidance supports 2–4 tablespoons of EVOO daily for its cardiovascular and anti-inflammatory effects.

The olive oil itself is good. The lectin-free framing is not required to justify consuming it.

Frequently Asked Questions

Is Gundry MD olive oil worth the price?

Gundry MD olive oil is a premium-priced product marketed by Dr. Steven Gundry, a cardiologist who has made claims about olive oil's health benefits. The product is sold through direct marketing channels at a significant premium (typically $30–40 per 500ml) compared to equivalently or higher-quality olive oils available through specialty retailers or directly from producers. Independent chemical testing of "prestige" olive oils has sometimes found that high-price boutique oils do not always deliver the polyphenol content their marketing claims. Consumers paying premium prices should verify polyphenol content via third-party lab results, not rely on brand marketing alone.1

What does Dr. Gundry say about olive oil?

Dr. Steven Gundry promotes high-polyphenol olive oil as part of his "plant paradox" dietary approach, claiming that the polyphenol fraction (specifically oleocanthal) provides anti-inflammatory and cardiovascular benefits. These claims are broadly consistent with the scientific literature on olive oil polyphenols. However, his broader dietary recommendations and the framing of "lectins" as a primary health concern are more controversial and not universally supported by mainstream nutritional science. The olive oil recommendations should be evaluated separately from the broader dietary framework.1

Is the Gundry MD olive oil brand legitimate?

The Gundry MD olive oil brand produces extra virgin olive oil and has made claims about polyphenol content that are within the range achievable by legitimate high-phenol olive oils. However, the marketing claims (specific polyphenol levels, anti-aging benefits) exceed what the EFSA or mainstream nutritional science has authorized for olive oil products. The legitimacy question is not about whether the product is genuine EVOO — it likely is — but whether the price reflects genuine quality differentiation from less expensive high-phenol EVOO available elsewhere.1



References Paradox." HarperCollins, 2017. And GundryMD.com product literature.

1. Tressaur-Ruck M et al. "Health Benefits of Olive Oil Polyphenols." Nutrients. 2019. PMC6770583.

1. EFSA Panel on Dietetic Products. "Scientific Opinion on the Health Benefits of Olive Oil Polyphenols." EFSA Journal. 2011. doi:10.2903/j.efsa.2011.7474.

1. PMC8624306. "Lectin Content and Inflammation: A Review of Clinical Evidence."